title: Natural isothiocyanates: genotoxic potential versus chemoprevention.
abstract: Isothiocyanates, occurring in many dietary cruciferous vegetables, show interesting chemopreventive activities against several chronic-degenerative diseases, including cancer, cardiovascular diseases, neurodegeneration, diabetes. The electrophilic carbon residue in the isothiocyanate moiety reacts with biological nucleophiles and modification of proteins is recognized as a key mechanism underlying the biological activity of isothiocyanates. The nuclear factor-erythroid-2-related factor 2 system, which orchestrates the expression of a wide array of antioxidant genes, plays a role in the protective effect of isothiocyanates against almost all the pathological conditions reported above. Recent emerging findings suggest a further common mechanism. Chronic inflammation plays a central role in many human diseases and isothiocyanates inhibit the activity of many inflammation components, suppress cyclooxygenase 2, and irreversibly inactivate the macrophage migration inhibitory factor. Due to their electrophilic reactivity, some isothiocyanates are able to form adducts with DNA and induce gene mutations and chromosomal aberrations. DNA damage has been demonstrated to be involved in the pathogenesis of various chronic-degenerative diseases of epidemiological relevance. Thus, the genotoxicity of the isothiocyanates should be carefully considered. In addition, the dose-response relationship for genotoxic compounds does not suggest evidence of a threshold. Thus, chemicals that are genotoxic pose a greater potential risk to humans than non-genotoxic compounds. Dietary consumption levels of isothiocyanates appear to be several orders of magnitude lower than the doses used in the genotoxicity studies and thus it is highly unlikely that such toxicities would occur in humans. However, the beneficial properties of isothiocyanates stimulated an increase of dietary supplements and functional foods with highly enriched isothiocyanate concentrations on the market. Whether such concentrations may exert a potential health risk cannot be excluded with certainty and an accurate evaluation of the toxicological profile of isothiocyanates should be prompted before any major increase in their consumption be recommended or their clinical use suggested.
authors.affiliation: Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy. Electronic address: carmela.fimognari@unibo.it.
authors.forename: Carmela
authors.initials: C
authors.lastname: Fimognari
authors.affiliation: Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
authors.forename: Eleonora
authors.initials: E
authors.lastname: Turrini
authors.affiliation: Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Ferruzzi
authors.affiliation: Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
authors.forename: Monia
authors.initials: M
authors.lastname: Lenzi
authors.affiliation: Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Hrelia
mesh_terms: D000975:Antioxidants / Q000627:therapeutic use; D018890:Chemoprevention; D006801:Humans; D017879:Isothiocyanates / Q000627:therapeutic use* / Q000633:toxicity*; D009153:Mutagens / Q000633:toxicity
chemical_list: D000975:Antioxidants; D017879:Isothiocyanates; D009153:Mutagens